`

Wugen

Biotechnology Research

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$172.0M
size-icon Size
51 - 200

Frequently Asked Questions About Wugen

What does Wugen do?+

Wugen is a clinical-stage biotechnology company developing the next generation of off-the-shelf memory natural killer (NK) and CAR-T cell therapies for cancer. Wugen is leveraging its proprietary Moneta platform and deep genomic engineering expertise to pioneer a new class of memory NK cell therapies to treat hematological and solid tumor malignancies. Wugen is based out of St. Louis, Missouri and San Diego, California

What is Wugen's industry? +

Wugen operates in the Biotechnology research industry.

What is Wugen's revenue? +

Wugen's revenue is 11m - 100m

What is Wugen's company size? +

Wugen has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.